[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344979-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-344979-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","economic-evaluation-of-22-hpv-vaccination-strategies-a-markov-model-analysis-targeting-chinese-males","Economic evaluation of 22 HPV vaccination strategies - A Markov model analysis - targeting Chinese males","","A decision-Markov model evaluates the lifetime effectiveness and cost-effectiveness of 22 male HPV vaccination strategies to prevent penile, anal, and oropharyngeal cancers in Chinese males. From a healthcare system perspective, strategies targeting males aged 14 and 40 are compared with no vaccination, using progression probabilities, incidence, utilities, and direct medical costs from published literature and national databases. Results show male vaccination is highly cost-effective, averting 73,724–416,654 cancer cases and 1,102–6,229 deaths depending on vaccine valency and coverage, with robustness confirmed by sensitivity analysis and support for policy inclusion of males.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/economic-evaluation-of-22-hpv-vaccination-strategies-a-markov-model-analysis-targeting-chinese-males/344979/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/economic-evaluation-of-22-hpv-vaccination-strategies-a-markov-model-analysis-targeting-chinese-males/344979.png","ImageObject",300,407,{"name":42,"@type":43},"Eliana","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What modeling approach is used to assess the HPV vaccination strategies?","Question",{"text":63,"@type":64},"The study uses a decision-Markov model to estimate lifetime effectiveness and cost-effectiveness across 22 vaccination strategies.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which cancer types and outcomes are considered?",{"text":68,"@type":64},"The analysis focuses on preventing penile, anal, and oropharyngeal cancers, reporting the number of cancer cases and deaths under different strategies.",{"name":70,"@type":61,"acceptedAnswer":71},"What do the results conclude about the value of male vaccination?",{"text":72,"@type":64},"Male vaccination is found to be highly cost-effective, with 20 of 22 strategies deemed highly cost-effective under a willingness-to-pay threshold of three times China’s GDP per capita, and sensitivity analysis supports robustness.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},344979,1790521079,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":33,"preview_urls":145},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","HUMAN VACCINES & IMMUNOTHERAPEUTICS 2026, VOL. 22, NO. 1, 2646398 [https://doi.org/10.1080/21645515.2026.2646398](https://doi.org/10.1080/21645515.2026.2646398)  \nRESEARCH ARTICLE     \nEconomic evaluation of 22 HPV vaccination strategies to minimize the risk of penile, anal, and oropharyngeal cancers in Chinese males: A Markov model analysis  \nDi Wanga,b*, Weihua Luoa*, Ruixi Qina, Gan Xua, Peipei Chaic, Bingjie Liud, Liangru Zhou a, and Xin Zhangd  \naSchool of Management, Beijing University of Chinese Medicine, Beijing, China; bSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; cDepartment of Health Economics and National Health Accounts Research, China National Health Development Research Center, Beijing, China; dSchool of Health Management, Harbin Medical University, Harbin, China  \nABSTRACT  \nMales can benefit significantly from human papillomavirus (HPV) vaccination. This study developed a decision-Markov model to evaluate the lifetime effectiveness and costeffectiveness of 22 HPV vaccination strategies for preventing penile, anal, and oropharyngeal cancers. From a healthcare system perspective, vaccination strategies targeting males aged 14 and 40 were compared against no vaccination. Key parameters, including disease progression probabilities, cancer incidence, health state utilities, and direct medical costs, were sourced from the published literature and national databases. We calculated the number of cancer cases and deaths under different strategies and compared their cost-effectiveness. Results demonstrated that male vaccination is highly cost-effective. Vaccinating 14-y-old males averted between 73,724 and 416,654 cancer cases and between 1,102 and 6,229 deaths, depending on the vaccine valency and coverage rate. Similarly, strategies targeting 40-y-old males demonstrated substantial benefits. Overall, 20 of the 22 strategies were deemed highly cost-effective against a willingness-to-pay threshold of three times the national gross domestic product per capita. Sensitivity analysis confirmed the results’ robustness. This study provides economic evidence to inform national HPV vaccination policies, demonstrating that including males, particularly adolescents, in vaccination programs represents a cost-effective investment for reducing the burden of HPV-associated cancers in China.  \nARTICLE HISTORY  \nReceived 8 September 2025 Revised 9 March 2026 Accepted 13 March 2026  \nKEYWORDS  \nHuman papillomavirus vaccine; penile cancer; anal cancer; oropharyngeal  \ncancer; China; economic evaluation  \nBackground  \nHuman papillomavirus (HPV) is one of the most common sexually transmitted pathogens worldwide, and persistent infection can cause cervical, penile, oropharyngeal and other head and neck cancers. The study showed that 31% of males aged 15 y and above infected with at least one genital HPV and 21% infected with at least one high-risk or carcinogenic HPV. 1 The prevalence of HPV infection among Chinese men who have sex with men (MSM) ranges from 40% to 60%,2 and the prevalence of HPV infection among HIVpositive males is as high as 33%–94 .8% .3 Approximately, 70,000 males suffer from cancer annually because of HPV infection worldwide.4 More than 60% of penile cancers and 90% of anal cancers in men in the United States are caused by HPV.5 The number of oropharyngeal cancers caused by HPV in males is also rising.6,7  \nHPV vaccination is considered to be an effective and cost-effective method of preventing HPV infection. It provides direct protection against genital warts and cancers (including penile, anal and oropharyngeal cancers) in males, reducing the risk of disease, as well as indirect protection and HPV prevention in females by reducing HPV transmission from infected males. In the UK, HPV vaccination of school-age boys yields  \nCONTACT Liangru Zhou  [zlr1220@126.com](zlr1220@126.com)  School of Management, Beijing University of Chines","cbCainaNf87VoIXh","https://ap.wps.com/l/cbCainaNf87VoIXh","pdf",2626955,"English","# Abstract\n# Background\n# Methods and model inputs\n# Results: cancer cases and deaths averted\n# Cost-effectiveness assessment\n# Sensitivity analysis and robustness\n# Policy implications","[{\"question\":\"What modeling approach is used to assess the HPV vaccination strategies?\",\"answer\":\"The study uses a decision-Markov model to estimate lifetime effectiveness and cost-effectiveness across 22 vaccination strategies.\"},{\"question\":\"Which cancer types and outcomes are considered?\",\"answer\":\"The analysis focuses on preventing penile, anal, and oropharyngeal cancers, reporting the number of cancer cases and deaths under different strategies.\"},{\"question\":\"What do the results conclude about the value of male vaccination?\",\"answer\":\"Male vaccination is found to be highly cost-effective, with 20 of 22 strategies deemed highly cost-effective under a willingness-to-pay threshold of three times China’s GDP per capita, and sensitivity analysis supports robustness.\"}]","Economic evaluation of 22 HPV vaccination strategies - A Markov model analysis - targeting Chinese males | PDF",1790056080,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8a4e42f4676fd3096bb5467e70427cca.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6986f8e636cc85e9b8000d4cbf9d2d2a.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99c4179b8244cf50a3dd6c935334aa89.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e0c3061054919fa1ddc78cf673435b2.webp",980,1306]